Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Synopsys & Intel Forge Partnership To Integrate Technical Building Blocks Into Chip Design -$INTC $SNPS $DIA $SPY $LTRN

By John F. Heerdink, Jr.

Reportedly, Synopsys (SNPS), a company specializing in chip design tools, and Intel Corporation (INTC) unveiled a collaborative agreement. Under this partnership, Synopsys’ collection of technical building blocks will be integrated into Intel’s offerings, aiming to enhance the chip design process.

The arrangement encompasses Synopsys’ intellectual property, which serves as readily available components for chip designers, expediting design procedures. Synopsys will curate a range of designs that align with Intel’s sophisticated manufacturing capabilities, including Intel 3 and Intel 18A.

Intel and Synopsys jointly confirmed the establishment of a framework that will facilitate the accessibility of this intellectual property for upcoming manufacturing processes. While the specific financial terms of the collaboration were not disclosed, its significance cannot be understated.

This collaboration holds strategic importance, particularly for Intel Foundry Services (IFS), the company’s contract manufacturing division. It signifies Intel’s ambition to position IFS as a viable contender in the competitive landscape, potentially rivaling established players like Taiwan Semiconductor Manufacturing Co Ltd and Samsung Electronics Co Ltd.

Intel Corporation (INTC) seeks to expand the boundaries of technology to provide the most amazing experience possible while designing, manufacturing, and selling integrated digital technology globally. To learn more about Intel Corporation (INTC) and to track its progress please visit the Vista Partners Intel Corporation Coverage Page

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm that is seeking to develop innovative medicines in areas of significant unmet medical need in oncology with a current focus on breast cancer and lung injury caused by cancer treatments.

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.

(Read Original Story: Intel adds Synopsys IP to advanced contract manufacturing in Reuters)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us